What is the treatment for trichotillomania?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Trichotillomania

Behavioral therapy with habit-reversal training (BT-HRT) is the first-line treatment for trichotillomania, demonstrating superior efficacy over all pharmacological interventions with a large effect size (SMD = -1.22). 1

First-Line Treatment Approach

Behavioral Therapy with Habit-Reversal Training

  • BT-HRT should be initiated as the primary treatment modality, showing significantly greater reduction in hair-pulling behavior compared to supportive therapy and all medication options 2, 3, 1
  • Group cognitive-behavioral therapy format is effective, with 22 sessions demonstrating significant improvement in hair-pulling behavior as measured by the Massachusetts General Hospital Hairpulling Scale 2
  • BT-HRT produces effect sizes approximately twice as large as clomipramine (ES = -1.14 vs -0.68) and substantially larger than SSRIs 3

When Behavioral Therapy Alone is Insufficient

If patients do not demonstrate significant improvement after 12 weeks of behavioral therapy, or if they are unwilling or unable to comply with behavioral interventions, pharmacotherapy should be added 4, 5

Pharmacological Treatment Algorithm

First-Line Pharmacotherapy: N-Acetylcysteine

  • N-acetylcysteine is the preferred first-line medication due to significant benefits (SMD = -0.75) and low risk of side effects 5, 1
  • This glutamate-modulating agent is particularly appropriate when behavioral therapy is not feasible or as augmentation to ongoing behavioral treatment 5

Second-Line Pharmacotherapy: Clomipramine

  • Clomipramine demonstrates moderate efficacy (SMD = -0.71) and is superior to placebo 3, 1
  • This tricyclic antidepressant should be considered when N-acetylcysteine proves insufficient 5

Alternative Pharmacotherapy: Olanzapine

  • Olanzapine shows significant benefit (SMD = -0.94) in single randomized trials 1
  • Consider this atypical antipsychotic when other agents have failed, though monitor carefully for metabolic side effects 1

Medications to Avoid

  • SSRIs (including sertraline) as monotherapy show no evidence of efficacy over placebo (ES = 0.02) and should not be used as single-agent treatment 3, 1

Optimal Treatment Strategy: Combined Modality

The combination of sertraline plus habit-reversal training produces larger gains and higher responder rates than either modality alone, making dual treatment the most effective approach for patients who can tolerate both interventions 4

  • Patients receiving combined treatment are much more likely to reach responder status at final evaluation compared to single modality treatment 4
  • This combination approach should be implemented when initial behavioral therapy shows inadequate response after 12 weeks 4

Critical Clinical Considerations

Interdisciplinary Approach Required

  • Trichotillomania requires comprehensive treatment planning with psychiatry-dermatology liaison and concurrent support services 5
  • Physicians must maintain a nonjudgmental, empathic, and inviting attitude, as patients often deny the habit 5

Social Support is Essential

  • Social support is a significant pillar to successful habit-reversal training 5
  • In pediatric cases, parents must be educated that negative feedback and punishment for hair pulling will not produce positive results 5
  • Familial support is crucial to achieving remission 5

Diagnostic Confirmation

  • Trichoscopy reveals abnormalities from stretching and fracture of hair shafts 5
  • Biopsy may be necessary if patients or parents have difficulty accepting the self-inflicted nature of the diagnosis 5
  • The condition typically presents with bizarre pattern nonscarring patchy alopecia with short hair and negative pull test 5

Common Pitfalls to Avoid

  • Do not use SSRI monotherapy as there is no evidence of efficacy over placebo 3, 1
  • Avoid relying solely on pharmacotherapy when behavioral therapy is available, as BT-HRT demonstrates substantially larger treatment effects 3, 1
  • Do not dismiss the importance of addressing comorbidities such as depression, anxiety, and social maladjustment, which often coexist with trichotillomania 2
  • Recognize that trichotillomania is classified as an obsessive-compulsive related disorder, not an impulse control disorder, which informs treatment selection 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.